Learn more about this affordable cancer screening test from idexx. 1 tom butera, dvm, chief executive officer of volition veterinary diagnostics development llc, said The element i+ immunodiagnostic analyzer supports diagnostic needs with the following tests
VolitionRx Breaks Down Supply Agreement of Nu.Q® Vet Cancer Tests with
Canine cancer, t4, ctsh, cortisol, progesterone, and ccrp
Introducing the nu.qtm vet cancer screening test for pet owners cancer is the most common cause of death in dogs over the age of 2 years in the us.
The nu.q® vet cancer test is a simple, affordable blood test designed for older dogs (7 years+) and younger ones (4 years+) at higher cancer risk, potentially due to lineage or breed specifics. The nu.q cancer screen test is a relatively new blood test for dogs to check for the 7 most common canine cancers. Volition, a multinational epigenetics company, announced today the availability of its nu.q vet cancer test through the idexx reference laboratory network in the us
